DEXCOM, INC. Deferred State and Local Income Tax Expense (Benefit)
DEXCOM, INC. (DXCM) reported Deferred State and Local Income Tax Expense (Benefit) of $16.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-12
- DEXCOM, INC. deferred state and local income tax expense (benefit) for the quarter ending 2017-12-31 was $0.00.
- DEXCOM, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was $16.00M.
- DEXCOM, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was -$2.00M, a 113.70% decline from fiscal 2023.
- DEXCOM, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was $14.60M.
- DEXCOM, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was -$17.60M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 3 month | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $16.00M 10-K · filed 2026-02-12 | ||
| 2024-12-31 | -$2.00M 10-K · filed 2026-02-12 | ||
| 2023-12-31 | $14.60M 10-K · filed 2026-02-12 | ||
| 2022-12-31 | -$17.60M 10-K · filed 2025-02-18 | ||
| 2021-12-31 | -$200.00K 10-K · filed 2024-02-08 | -$3.40M 10-K · filed 2022-02-14 | |
| 2020-12-31 | -$50.50M 10-K · filed 2023-02-09 | -$51.40M 10-K · filed 2021-02-11 | |
| 2019-12-31 | $0.00 10-K · filed 2022-02-14 | ||
| 2018-12-31 | -$500.00K 10-K · filed 2021-02-11 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-02-21 | $0.00 10-K · filed 2020-02-13 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 | ||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |